ALLMedicine™ Early Pregnancy Loss Center

Apr 6th, 2021 - The aim of this study was to examine the role of growth factors associated with angiogenesis and oxidative stress in the pathogenesis of spontaneous miscarriage. We performed a comparative mRNA expression analysis of VEGF, PlGF, Flt-1, Angiogenin ...

Mar 18th, 2021 - Valproic acid (VPA), a widely prescribed antiepileptic drug and an effective treatment for bipolar disorder and neuropathic pain, results in multiple developmental defects following in utero exposure. Uterine decidua provides nutritional and physi...

Mar 2nd, 2021 - To objective of this study is to discuss the ultrasonographic technique to diagnose uterine enhanced myometrial vascularity/arteriovenous malformation (EMV/AVM) and differentiate it from retained products of conception. The study also reviews the ...

Feb 25th, 2021 - Most patients can safely begin using hormonal contraception at any point in their menstrual cycle. An evidence-based, flexible, patient-centered approach to initiating contraception promotes health and enhances patients' reproductive autonomy. A r...

Feb 5th, 2021 - Pregnancy is an extraordinarily complex immunological process. For successful pregnancy maintenance the maternal immune system must adapt to and tolerate the semi-allogenic fetus at the fetomaternal interface of the placenta. This balance is regul...

Dec 30th, 2018 - Medical abortion care encompasses the management of various clinical conditions including spontaneous and induced abortion (both viable and non-viable pregnancies), incomplete abortion and intrauterine fetal demise, as well as post-abortion contra.

Aug 29th, 2018 - Early pregnancy loss, or loss of an intrauterine pregnancy within the first trimester, is encountered commonly in clinical practice. Obstetricians and gynecologists should understand the use of various diagnostic tools to differentiate between via...

May 1st, 2015 - Early pregnancy loss, or loss of an intrauterine pregnancy within the first trimester, is encountered commonly in clinical practice. Obstetricians and gynecologists should understand the use of various diagnostic tools to differentiate between via...

Apr 6th, 2021 - The aim of this study was to examine the role of growth factors associated with angiogenesis and oxidative stress in the pathogenesis of spontaneous miscarriage. We performed a comparative mRNA expression analysis of VEGF, PlGF, Flt-1, Angiogenin ...

Mar 18th, 2021 - Valproic acid (VPA), a widely prescribed antiepileptic drug and an effective treatment for bipolar disorder and neuropathic pain, results in multiple developmental defects following in utero exposure. Uterine decidua provides nutritional and physi...

Mar 2nd, 2021 - To objective of this study is to discuss the ultrasonographic technique to diagnose uterine enhanced myometrial vascularity/arteriovenous malformation (EMV/AVM) and differentiate it from retained products of conception. The study also reviews the ...

Feb 25th, 2021 - Most patients can safely begin using hormonal contraception at any point in their menstrual cycle. An evidence-based, flexible, patient-centered approach to initiating contraception promotes health and enhances patients' reproductive autonomy. A r...

Feb 5th, 2021 - Pregnancy is an extraordinarily complex immunological process. For successful pregnancy maintenance the maternal immune system must adapt to and tolerate the semi-allogenic fetus at the fetomaternal interface of the placenta. This balance is regul...

Jan 11th, 2021 - Black women are significantly more likely than non-Black women to develop major depression within a month of early pregnancy loss, based on data from a secondary analysis of 300 women. Black women are significantly more likely than non-Black women...

Feb 6th, 2020 - Women who have experienced early pregnancy loss may experience clinically significant posttraumatic stress, anxiety, and depression 9 months after the loss, new research suggests. AkilinaWinner/Thinkstock The outcomes of a prospective cohort study.

Jan 20th, 2020 - Women experienced moderate to severe depression, moderate to severe anxiety, or posttraumatic stress a month following early pregnancy loss from miscarriage or ectopic pregnancy, and for some patients, these stress-related conditions persisted at ...

Dec 9th, 2019 - CHALLENGES TO IMPLEMENTATION FDA restrictions limit availability of mifepristone The main challenge to implementation is the availability of mifepristone. Mifepristone was approved by the US Food and Drug Administration in 2000.

Aug 6th, 2019 - Complications and intervention Major complications are rare with medical management of first-trimester abortion and early pregnancy loss, but can include ongoing pregnancy, which is infrequent but possible; incomplete abortion, which is easily man.